Vivimed Labs under insolvency, invites resolution bids

Regulatory & Legal View source PDF Explain this filing

VIVIMEDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.6%Reaction day

₹6.21

prior close

₹6.19

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.1%-3.7% vs market

On the reaction day the stock moved 3.7 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

-0.6

15m

-1.5

30m

-3.9

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

-2.6+1.1-3.7

Next day

-2.4+1.6-4.0

-5.0+2.4-7.4

-5.0+3.3-8.3

-5.0+2.5-7.5

-5.5+2.4-7.9

-3.5+1.5-5.1

15d

-10.6+2.6-13.3

-15.6+2.2-17.8

-17.1+6.8-23.9

-8.4+5.9-14.3

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Vivimed Labs has entered Corporate Insolvency Resolution Process. Form G has been published inviting Expression of Interest from potential resolution applicants. The pharma firm has manufacturing units in Hyderabad, Haridwar, Kashipur, and Bidar with 352 employees. Revenue was 103.60 Cr in FY25 and 48.23 Cr for nine months ended Dec 2025. Last date for bids is June 29, 2026, and resolution plans are due by August 28, 2026.

Likely market impact

Existing shareholders likely to face significant dilution or value loss depending on the resolution plan approved under IBC.